NCT02310750 - A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

February 29, 2016

Conditions

Plaque Psoriasis

Interventions

DRUG

PF-06700841 oral solution/suspension

Oral solution or suspension of study drug PF-06700841 (once daily or twice daily during multiple dosing periods)

OTHER

Placebo

Matching placebo given during the single ascending and multiple dose periods

DRUG

PF-06700841 tablet

PF-06700841 tablet formulation administered during the bioavailability / food effect investigation

Trial Locations (1)

Anaheim Clinical Trials, LLC, Anaheim